دورية أكاديمية

In -Class Transition from Bortezomib-Based Therapy to IRd is an Effective Approach in Newly Diagnosed Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان: In -Class Transition from Bortezomib-Based Therapy to IRd is an Effective Approach in Newly Diagnosed Multiple Myeloma
المؤلفون: Rifkin, Robert M, Costello, Caitlin L, Birhiray, Ruemu E, Kambhampati, Suman, Richter, Joshua, Abonour, Rafat, Lee, Hans C, Stokes, Michael, Ren, Kaili, Stull, Dawn Marie, Cherepanov, Dasha, Bogard, Kimberly, Noga, Stephen J, Girnius, Saulius
المساهمون: Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
المصدر: Future Oncology ; volume 20, issue 3, page 131-143 ; ISSN 1479-6694 1744-8301
بيانات النشر: Informa UK Limited
سنة النشر: 2023
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.2217/fon-2023-0272
الإتاحة: https://doi.org/10.2217/fon-2023-0272Test
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.115A06B
قاعدة البيانات: BASE